AR038701A1 - 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su preparacion y medicamentos que comprenden el compuesto activo - Google Patents

3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su preparacion y medicamentos que comprenden el compuesto activo

Info

Publication number
AR038701A1
AR038701A1 ARP030100624A ARP030100624A AR038701A1 AR 038701 A1 AR038701 A1 AR 038701A1 AR P030100624 A ARP030100624 A AR P030100624A AR P030100624 A ARP030100624 A AR P030100624A AR 038701 A1 AR038701 A1 AR 038701A1
Authority
AR
Argentina
Prior art keywords
group
formula
substituted
compounds
oxadiazol
Prior art date
Application number
ARP030100624A
Other languages
English (en)
Spanish (es)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of AR038701A1 publication Critical patent/AR038701A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
ARP030100624A 2002-02-28 2003-02-26 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su preparacion y medicamentos que comprenden el compuesto activo AR038701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208987A DE10208987A1 (de) 2002-02-28 2002-02-28 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen

Publications (1)

Publication Number Publication Date
AR038701A1 true AR038701A1 (es) 2005-01-26

Family

ID=27740558

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100624A AR038701A1 (es) 2002-02-28 2003-02-26 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su preparacion y medicamentos que comprenden el compuesto activo

Country Status (22)

Country Link
EP (1) EP1480960B1 (https=)
JP (1) JP4486363B2 (https=)
KR (1) KR20040095240A (https=)
CN (1) CN1639137A (https=)
AR (1) AR038701A1 (https=)
AT (1) ATE557012T1 (https=)
AU (1) AU2003226977A1 (https=)
BR (1) BR0307921A (https=)
CA (1) CA2477031A1 (https=)
CO (1) CO5611146A2 (https=)
DE (1) DE10208987A1 (https=)
HR (1) HRP20040782A2 (https=)
HU (1) HUP0402671A3 (https=)
IL (1) IL163683A0 (https=)
MA (1) MA27172A1 (https=)
MX (1) MXPA04007960A (https=)
NO (1) NO20044090L (https=)
PE (1) PE20030928A1 (https=)
PL (1) PL370423A1 (https=)
RU (1) RU2004128933A (https=)
TW (1) TW200400951A (https=)
WO (1) WO2003072555A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
JP2008517976A (ja) 2004-10-25 2008-05-29 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb1カンナビノイド受容体拮抗薬及びカリウムチャンネルオープナーから成る、真性糖尿病1型、肥満及び関連症状の治療用の医薬組成物
JP2011507952A (ja) * 2007-12-27 2011-03-10 バイアル−ポルテラ アンド シーエー,エス.エー. 医療用途用5−o−置換3−n−フェニル−1、3、4−オキサジアゾロン類
TW201028406A (en) 2008-12-23 2010-08-01 Bial Portela & Ca Sa 5-O-substituted 3-N-aryl-1,3,4-oxadiazolones for medical use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
TR200401217T4 (tr) * 2000-03-07 2004-06-21 Aventis Pharma Deutschland Gmbh İkameli 3-Fenil-5-Alkoksi-1,3,4-Oksdiazol-2-one (ve) hormona duyarlı lipazın önlenmesinde kullanılması

Also Published As

Publication number Publication date
TW200400951A (en) 2004-01-16
AU2003226977A1 (en) 2003-09-09
BR0307921A (pt) 2004-12-21
CA2477031A1 (en) 2003-09-04
IL163683A0 (en) 2005-12-18
ATE557012T1 (de) 2012-05-15
HUP0402671A3 (en) 2006-07-28
JP2005519085A (ja) 2005-06-30
MXPA04007960A (es) 2004-11-26
EP1480960A1 (de) 2004-12-01
WO2003072555A1 (de) 2003-09-04
JP4486363B2 (ja) 2010-06-23
MA27172A1 (fr) 2005-01-03
PL370423A1 (en) 2005-05-30
NO20044090L (no) 2004-11-04
CN1639137A (zh) 2005-07-13
EP1480960B1 (de) 2012-05-09
PE20030928A1 (es) 2003-12-17
DE10208987A1 (de) 2003-09-11
CO5611146A2 (es) 2006-02-28
RU2004128933A (ru) 2005-04-20
HRP20040782A2 (en) 2005-02-28
HUP0402671A2 (hu) 2005-04-28
KR20040095240A (ko) 2004-11-12

Similar Documents

Publication Publication Date Title
CO5690550A2 (es) Derivados de 3-aminopirrolidina como moduladores de recepto- res de quimocina
MY140039A (en) Pyrido-(2,1-a)-isoquinoline derivatives as dpp-iv inhibitors
PE20090477A1 (es) Derivados de oxazol como inhibidores de los canales de sodio
AR050267A1 (es) Derivados de urea ciclicos sustituidos con heterociclo, su preparacion y su uso farmaceutico como inhibidores de quinasa
RU2010136665A (ru) Новые пиридиноны и пиридазиноны
PE20061123A1 (es) Derivados de amida como inhibidores de la hidrolasa de amida de acido graso
PE20070051A1 (es) Serin-amidas sustituidas con heteroaroilo
PE20050864A1 (es) Compuestos de heterociclilamino como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
RU2011103234A (ru) Новые фенилпиразиноны в качестве ингибиторов киназы
ES2175919T3 (es) Derivados del camptothecin con actividad antitumoral.
RU2011140064A (ru) Ингибиторы тирозинкиназы брутона
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
AR079327A1 (es) Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida
HRP20080493T3 (hr) Supstituirani kinolinski derivati kao mitotski inhibitori kinezina
PE20050265A1 (es) Derivados de acido alquilarilo como inhibidores de diacilglicerol aciltransferasa tipo 1 (dgat-1)
AR042936A1 (es) Derivados de urea ciclica, su preparacion y su utilizacion farmaceutica como inhibidores de quinasas
AR039226A2 (es) Compuestos utiles como intermediarios de preparacion y procedimientos
RU2009137255A (ru) Содержащие азот гетероциклические соединения, их получение и применение их в качестве антибактериальных лекарственных средств
MX2007007428A (es) Compuestos heterociclicos, antagonistas de ccr2b.
AR034585A1 (es) Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos
AR038701A1 (es) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas sustituidas, su preparacion y medicamentos que comprenden el compuesto activo
AR041786A1 (es) Derivados de azetidina como antagonistas del receptor ccr-3, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la elaboracion de un medicamento
ECSP066415A (es) 2-carbonilamino-6-piperidinaminopiridinas sustituidas y 1-carbonilamino-3-piperidinaminobenzenos sustituidos como 5-ht1f agonistas
RU2008134424A (ru) Способ получения производных рапамицина

Legal Events

Date Code Title Description
FB Suspension of granting procedure